Our business development team talks with healthcare decision makers all day, every day. They discuss medication safety best practices. They talk about utilizing data and analytics to make evidence based decisions. They teach on how post approval side effect data can be properly utilized in Formulary and P&T decisions, as well as how to use the data to better react to FDA trigger events. And sometimes, they just get hung up on.

From all of the conversations we’ve had in the past seven months since AdverseEvents Explorer officially launched, we have been able to identify three “types” of people that we talk to, that are involved in drug safety. Enlightened Drug Safety Professionals, Progressive Drug Safety Professionals, and Members of the Old Guard.

Based on these types, we can, with quite a bit of accuracy, predict their reaction to a demonstration of AdverseEvents Explorer.

The enlightened ones will love it. The progressive ones will like it. The Members of the Old Guard will hate it.

 

Related Read: Pharma’s Gonna Hate, and We Just Shake it Off

 

The interesting thing is that it doesn’t matter what type of organization the person is with. It can be a large health plan, a regional health system, an independent hospital, a top 5 PBM, a small consultancy, a large pharma company, or a product liability insurer. We have clients across the healthcare spectrum, and all of the people we talk with fall into one of these 3 categories.

 

So, what kind of drug safety professional are you? Take the quick quiz below to find out.

For every "a" give yourself 1 pt, for every "b", 0 points, and every "c", -1 points;

 

1. When you hear people talking about the FDA Adverse Event Reporting System, you:
a. Smile because you know how useful it is in making drug prescribing decisions
b. Try and listen closely to see if they have finally found a way to make it useful
c. Laugh and carry on talking with your pharma rep

2. When the FDA communicates a label change for a drug, you:
a. Want to know what the data behind the decision looks like and try and get a better understanding of what other drugs in the class look like
b. Try and determine if the label change should affect prescribing decisions
c. Not worry about it- it’s not like it’s been withdrawn from the market

3. Disproportionality Analysis is:
a. A great way to compare the side effect profiles of drugs by looking at the relative frequency of a side effect occurring
b. Something I heard about in stats class but haven’t used since
c. Something that only pharmacovigilance folks inside FDA and pharma can possibly understand and use.

4. If someone told you that there was a way to predict that the FDA would take action on a drug up to 3 years prior, you would:
a. Use it in your decision making process
b. Use it as a watchlist for potential safety concerns
c. Disregard it as witchcraft

5. Is improving patient safety your ultimate goal?
a. Yes. And at the same time I want to reduce the cost of healthcare.
b. Yes.
c. Yes. At least that is what I tell people.

Answer Key:

If you scored 3+ points you are an Enlightened Drug Safety Professional. You embrace data to make real world pharmacy and med safety decisions and understand that Big Data analytics have a real and important place in evidence based decision making. You keep on top of changes in medication safety best practices and believe that by driving safe prescribing behavior you can improve patient outcomes and lower the cost burden adverse events has on the healthcare system. You believe that while pharmaceutical companies and the FDA are very important, they should not be the only authority that can make use of data and as a healthcare decision maker, you have an obligation to ensure you are using all of the data available in your safety framework. You will LOVE AdverseEvents Explorer and should set up a trial ASAP

Share your results!




If you scored 0-2 points you are a Progressive Drug Safety Professional. While not yet enlightened, you understand that there is a paradigm shift occurring throughout healthcare that enables healthcare decision makers to use previously unavailable data to make the best decisions possible. You know that there are new best practices for medication safety out there that will improve patient outcomes and lower the cost burden of adverse events, but you’ve yet to implement any in your day-to-day. Pharmaceutical companies and the FDA are your sole source of actionable post approval data on drugs. While you don’t whole-heartedly believe that they should be the only authority that can use the data, you have no other way of gaining insight into what is going on post approval. You will LIKE AdverseEvents Explorer and should set up a trial ASAP.

Share your results!




If you scored < 0 points you are a Member of the Old Guard Drug Safety Professional. You believe that data should only be in the hands of a select few pharmacovigilance employees at pharmaceutical companies and government agencies such as the FDA. You cringe when you hear about open access to data and don’t believe that anyone other than pharmaceutical companies and the FDA should have access. You will HATE AdverseEvents Explorer but should probably still set up a trial to see how much you hate it!

Share your results!




Are we missing any types? Let us know in the comments below!


Subscribe to Drug Safety Monitor


Jim Davis

Jim Davis

Executive Vice President

Jim Davis LinkedinJim Davis Twitter

 

Topics: Drug Safety

Jim Davis

Written by Jim Davis

As Executive Vice President, Jim is responsible for the commercialization strategy for Advera Health Analytics.